Document Detail


Valproic acid, trichostatin and their combination with hemin preferentially enhance gamma-globin gene expression in human erythroid liquid cultures.
MedLine Citation:
PMID:  11454524     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND AND OBJECTIVES: In addition to conventional therapy, current treatment of thalassemia and sickle cell anemia includes inducers of hemoglobin F synthesis (hydroxyurea, erythropoietin, azacytidine and butyrate). However, because of concerns about the dose-limiting myelotoxicity, potential carcinogenicity and high cost of the above agents, an intensive search for less toxic or more effective drugs is ongoing. In this study we tested the effect of valproic acid and trichostatin, alone or in combination with hemin, on gamma chain synthesis in human erythroid liquid cultures. DESIGN AND METHODS: The agents were tested on erythroid human liquid cultures derived from normal peripheral blood, peripheral blood from beta(s)/beta(thal) patients, normal cord blood and normal bone marrow samples. The effect of the agents was expressed as increase of gamma/gamma+beta m-RNA, measured with competitive reverse transcriptase-polymerase chain recation (RT-PCR), or as increase of HbF, measured by high performance liquid chromatography (HPLC). RESULTS: Addition of valproic acid or trichostatin to human erythroid cell cultures preferentially enhanced gamma mRNA synthesis in all blood samples (2.9 to 3.5-fold). The addition of hemin enhanced the effect up to 10-fold. INTERPRETATION AND CONCLUSIONS: Valproic acid, trichostatin and their combination with hemin (all three FDA-approved drugs) preferentially increase gamma-globin chain synthesis and may be helpful for the treatment of hemoglobinopathies.
Authors:
P Marianna; P Kollia; S Akel; Y Papassotiriou; A Stamoulakatou; D Loukopoulos
Related Documents :
6372974 - Osmoregulation in klebsiella pneumoniae: enhancement of anaerobic growth and nitrogen f...
7196914 - Gamma-aminobutyric acid system in rat oviduct.
1407654 - The immediate consequences of middle cerebral artery occlusion on gaba synthesis in mou...
19064324 - Behaviour and fluxes of natural radionuclides in the production process of a phosphoric...
3418494 - Kinetic analysis of albumin-mediated uptake of warfarin by perfused rat liver.
22326554 - Omega-3 fatty acids and their lipid mediators: towards an understanding of resolvin and...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Haematologica     Volume:  86     ISSN:  0390-6078     ISO Abbreviation:  Haematologica     Publication Date:  2001 Jul 
Date Detail:
Created Date:  2001-07-16     Completed Date:  2002-01-02     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  0417435     Medline TA:  Haematologica     Country:  Italy    
Other Details:
Languages:  eng     Pagination:  700-5     Citation Subset:  IM    
Affiliation:
First Department of Medicine, University of Athens, Laikon Hospital, Greece. dloukop@otenet.gr
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antifungal Agents / pharmacology
Cells, Cultured / drug effects
Drug Interactions
Erythroid Precursor Cells / cytology,  drug effects,  metabolism
GABA Agents / pharmacology
Gene Expression / genetics
Globins / drug effects*,  genetics
Hemin / pharmacology*
Humans
Hydroxamic Acids / pharmacology*
Valproic Acid / pharmacology*
beta-Thalassemia / pathology
Chemical
Reg. No./Substance:
0/Antifungal Agents; 0/GABA Agents; 0/Hydroxamic Acids; 16009-13-5/Hemin; 58880-19-6/trichostatin A; 9004-22-2/Globins; 99-66-1/Valproic Acid

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Quantification of human cells in NOD/SCID mice by duplex real-time polymerase-chain reaction.
Next Document:  Molecular analysis of patients with relapsed or refractory intermediate-high grade non-Hodgkin's lym...